CLINICAL_TRIALS
trial_result
· 2025-12-23
Clinical Trial Update: Study of Two Dosages of Roaccutane in Cystic Acne [Phase 4]
Summary
A Phase 4 study evaluating two dosages of Roaccutane (isotretinoin) for cystic acne has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Premier Specialists, Australia | Conditions: Acne Cystic | Phase 4 | Status: COMPLETED